I. Gomes

c-Met expression in renal cell carcinoma with bone metastases

S. Casimiro, Rita Silva Paiva, I. Gomes, 2020, Journal of bone oncology.

Exploring new pathways in endocrine-resistant breast cancer

S. Casimiro, I. Gomes, T. Pacheco, 2022, Exploration of targeted anti-tumor therapy.

A Tailored Approach for Appendicular Impending and Pathologic Fractures in Solid Cancer Metastases

Luís Costa, S. Casimiro, I. Gomes, 2022, Cancers.

Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer

N. Barbosa-Morais, Sara Henriques, S. Casimiro, 2020, Oncotarget.

The Roadmap of RANKL/RANK Pathway in Cancer

S. Casimiro, I. Gomes, L. Costa, 2021, Cells.

Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer

Luís Costa, S. Casimiro, I. Gomes, 2023, Cell reports. Medicine.

The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer

S. Casimiro, I. Gomes, C. Abreu, 2023, Cancers.

Identification of SPRY4 as a novel candidate susceptibility gene for familial non-medullary thyroid cancer.

J. Ramalho, I. Gomes, V. Leite, 2021, Thyroid : official journal of the American Thyroid Association.